Literature DB >> 31502362

Valuing health using EQ-5D: The impact of chronic diseases on the stock of health.

Eduardo Sánchez-Iriso1,2, Maria Errea Rodríguez3, Juan Manuel Cabasés Hita1,4.   

Abstract

Chronic diseases strongly affect individuals' health status. In aggregate terms, this impact is reflected by the stock of health, which measures the amount of health of a population in a given period of time. The objectives of this study were to measure the relative burden of chronic illnesses by assessing health-related quality of life using the EQ-5D-5L instrument, to rank diseases according to their associations with the stock of health, and to calculate the stock of health of the Spanish population and the amount of health loss attributable to each chronic disease from a social perspective. Data were gathered from the Spanish Health Survey (ENSE 2011-2012, N = 20,587). A population weighted least squares model was used. Chronic diseases represent 19.19% of the stock of health losses in Spain compared with a country free from those diseases. In Spain, the stock of health in 2011 was 31.86 million units on the visual analog scale. The diseases with the strongest impact in terms of loss of stock of health at the individual level were mental illness and embolism, stroke, or cerebral hemorrhage. Collectively, the diseases with the largest impact included osteoarthritis, arthritis, or rheumatism; chronic back pain; and high blood pressure.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  EQ-5D; EQ-5D-5L; chronic diseases; stock of health; visual analog scale

Mesh:

Year:  2019        PMID: 31502362     DOI: 10.1002/hec.3952

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  2 in total

Review 1.  Health State Utility Values in People With Stroke: A Systematic Review and Meta-Analysis.

Authors:  Raed A Joundi; Joel Adekanye; Alexander A Leung; Paul Ronksley; Eric E Smith; Alexander D Rebchuk; Thalia S Field; Michael D Hill; Stephen B Wilton; Lauren C Bresee
Journal:  J Am Heart Assoc       Date:  2022-06-22       Impact factor: 6.106

2.  Economic burden and health-related quality of life in tenosynovial giant-cell tumour patients in Europe: an observational disease registry.

Authors:  J Lopez-Bastida; I Aranda-Reneo; B Rodríguez-Sánchez; L M Peña-Longobardo; X Ye; P Laeis; E M Fronk; E Palmerini; A Leithner; M A J Van de Sande
Journal:  Orphanet J Rare Dis       Date:  2021-07-02       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.